Zheng Gang Zhang Selected Research

Zheng Gang Zhang Research Topics

Disease

79	Stroke (Strokes) 01/2025 - 04/2002
27	Embolic Stroke 01/2023 - 04/2002
21	Infarction (Infarctions) 01/2025 - 02/2002
20	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 10/2021 - 07/2003
18	Peripheral Nervous System Diseases (PNS Diseases) 01/2023 - 12/2012
14	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2023 - 11/2004
10	Ischemic Stroke 01/2025 - 07/2005
10	Thrombosis (Thrombus) 01/2021 - 06/2003
10	Ischemia 08/2013 - 04/2002
9	Brain Ischemia (Cerebral Ischemia) 01/2020 - 04/2002
8	Neoplasms (Cancer) 02/2021 - 06/2004
7	Glioma (Gliomas) 09/2009 - 05/2006
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 11/2010
5	Demyelinating Diseases (Demyelinating Disease) 01/2022 - 01/2015
4	Neuroinflammatory Diseases 01/2023 - 03/2017
4	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2022 - 04/2015
4	Inflammation (Inflammations) 01/2021 - 11/2005
3	Closed Head Injuries 01/2019 - 06/2013
3	Hyperglycemia 12/2018 - 01/2016
3	Glioblastoma (Glioblastoma Multiforme) 01/2007 - 05/2006
2	Nervous System Diseases (Neurological Disorders) 01/2022 - 04/2016
2	Diabetic Neuropathies (Diabetic Neuropathy) 01/2020 - 01/2015
2	Brain Concussion (Cerebral Concussion) 01/2019 - 04/2015
2	Gliosis 01/2019 - 04/2015
2	Body Weight (Weight, Body) 01/2018 - 03/2009
2	Brain Injuries (Brain Injury) 04/2015 - 06/2004
2	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 11/2014 - 01/2012
2	Embolism (Embolus) 11/2009 - 12/2004
1	Hypotension (Low Blood Pressure) 01/2023
1	Septic Shock (Toxic Shock Syndrome) 01/2023

Drug/Important Bio-Agent (IBA)

21	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2023 - 06/2003
19	MicroRNAs (MicroRNA)IBA 01/2025 - 01/2011
18	Therapeutic UsesIBA 01/2025 - 01/2011
16	Proteins (Proteins, Gene)FDA Link 01/2025 - 06/2003
10	Neuroprotective AgentsIBA 04/2014 - 07/2003
9	FibrinIBA 03/2017 - 06/2003
8	Bromodeoxyuridine (BrdU)IBA 01/2022 - 11/2003
8	cerebrolysinIBA 01/2021 - 11/2010
8	ThymosinIBA 10/2019 - 01/2011
7	NAD (NADH)IBA 01/2023 - 12/2017
7	Atorvastatin (Lipitor)FDA Link 11/2009 - 06/2003
6	Peptides (Polypeptides)IBA 03/2019 - 11/2010
6	Sildenafil Citrate (Viagra)FDA Link 01/2016 - 04/2005
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2008 - 04/2002
5	Myelin Basic ProteinIBA 01/2022 - 08/2012
5	Phosphodiesterase 5 InhibitorsIBA 02/2017 - 04/2005
5	Erythropoietin FDA Link 11/2010 - 08/2007
4	Amyloid (Amyloid Fibrils)IBA 01/2022 - 04/2015
4	Plasminogen Activator Inhibitor 1IBA 12/2019 - 02/2010
4	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 01/2016 - 04/2005
4	Histone Deacetylases (Histone Deacetylase)IBA 01/2016 - 11/2014
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2006 - 06/2003
3	CuprizoneIBA 01/2022 - 04/2016
3	goralatideIBA 01/2019 - 04/2014
3	Phosphates (Orthophosphate)IBA 11/2013 - 07/2010
3	Bortezomib (Velcade)FDA Link 08/2012 - 01/2006
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 09/2009 - 06/2004
3	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2007 - 04/2002
3	Messenger RNA (mRNA)IBA 06/2006 - 04/2002
3	Coenzyme A (CoA)IBA 11/2005 - 11/2004
2	CytokinesIBA 01/2022 - 06/2010
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2021 - 01/2021
2	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2017
2	Angiopoietin-1IBA 10/2019 - 04/2002
2	Glucose (Dextrose)FDA LinkGeneric 06/2018 - 10/2006
2	Blood Glucose (Blood Sugar)IBA 01/2018 - 01/2015
2	Histones (Histone)IBA 02/2017 - 11/2014
2	2',3'-Cyclic-Nucleotide Phosphodiesterases (2',3' Cyclic Nucleotide Phosphodiesterase)IBA 04/2016 - 06/2010
2	Nerve Growth Factors (Neurotrophins)IBA 04/2015 - 11/2010
2	Phosphotransferases (Kinase)IBA 08/2012 - 11/2007
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2011 - 04/2007
2	carbamylated erythropoietinIBA 02/2011 - 08/2007
2	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 05/2010 - 11/2005
2	SynaptophysinIBA 02/2010 - 06/2003
2	Erythropoietin Receptors (Erythropoietin Receptor)IBA 01/2010 - 09/2008
2	fluorescein isothiocyanate dextranIBA 07/2009 - 01/2005
2	Small Interfering RNA (siRNA)IBA 06/2009 - 05/2007
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 10/2008 - 11/2005
2	PAR-1 ReceptorIBA 10/2008 - 06/2006
2	LigandsIBA 08/2008 - 08/2007
2	ChemokinesIBA 08/2007 - 05/2006
2	Matrix Metalloproteinases (MMPs)IBA 05/2007 - 06/2006
2	Peptide Hydrolases (Proteases)FDA Link 04/2007 - 11/2005
2	Oxygen (Dioxygen)IBA 10/2006 - 05/2006
2	Thromboplastin (Tissue Factor)IBA 06/2006 - 11/2005
2	Oxidoreductases (Dehydrogenase)IBA 11/2005 - 11/2004
2	von Willebrand FactorIBA 11/2005 - 02/2002
2	Glycoproteins (Glycoprotein)IBA 07/2005 - 06/2003
1	Semaphorins (Semaphorin)IBA 01/2025
1	rhoA GTP-Binding ProteinIBA 01/2025
1	PolymersIBA 01/2023
1	Vasoconstrictor AgentsIBA 01/2023

Therapy/Procedure

22	Therapeutics 01/2022 - 02/2003
10	Thrombolytic Therapy 04/2015 - 06/2003
6	Intravenous Administration 01/2020 - 04/2003
6	Lasers (Laser) 03/2011 - 11/2003
4	Aftercare (After-Treatment) 12/2013 - 11/2005
3	Photochemotherapy (Photodynamic Therapy) 09/2009 - 06/2004
2	Transplantation 11/2005 - 02/2003
2	Cell- and Tissue-Based Therapy (Cell Therapy) 11/2005 - 02/2003